Cellectar Biosciences, Inc. — Director's Dealing 2015

Mar 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2015-02-26

Reporting Person: Genn John Patrick (VP of Business Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-26	Stock option (right to buy)	$2.69	A	10000	Acquired	2025-02-26	Common Stock (10000)	Direct

Footnotes

F1: Option vests in equal quarterly increments over a period of three years from the date of grant.